ABVC BioPharma opened lower at $0.98, compared with its previous close of $0.99. In the last trading session, the stock traded between $0.89 and $1.00. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in ABVC BioPharma is now worth
$ 2.82
Resulting in a loss of
$ 97.18 (97.18%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
No analyst rating data available.
Markets Today
Today's Change
$-0.03 (-2.93%)
Day High
$1.00
Day Low
$0.89
Day Open
$0.98
Prev Close
$0.99
Volume
42,377
1W Return
-4.08%
1M Return
-1.33%
3M Return
-1.83%
6M Return
-5.59%
1Y Return
-66.68%
Fundamentals
Market Cap ($ Mn)
26
PE Ratio
-
PB Ratio
2.03
PEG Ratio
-
ROE
-113.78%
ROCE
-83.63%
EPS (TTM)
$-0.06
Investment Returns
1 Week
-4.08%
1 Month
-1.33%
3 Months
-1.83%
6 Months
-5.59%
9 Months
-44.34%
Financials
Quarterly
All values in $ Mn
0.0
Dec 24
0.0
Mar 25
0.0
Jun 25
0.8
Sep 25
0.0
Dec 25
0.0
Mar 26
Updates
2Nov
ABVC BioPharma closes $3.39 million convertible note offering
ABVC BioPharma closed a private placement of OID senior convertible notes for $3.39 million in gross proceeds. The notes have an aggregate principal amount of $4,106,060 and mature on June 30, 2027. Net proceeds will fund working capital, subsidiaries, and a $625,000 settlement with Lind Global Fund II LP. Conversion price is set at 85% of the average three-day VWAP prior to conversion.
10 days ago
13Aug
ABVC BioPharma postpones BioKey share distribution to August 21
ABVC BioPharma delayed its BioKey (Cayman) share distribution to August 21, 2026, to address pending regulatory and tax issues. The record date of July 24, 2026, and the 0.169464 distribution ratio remain unchanged. The company will announce a new ex-dividend date after finalizing logistics with Nasdaq and DTC.
